# RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook
Canonical URL: https://biopharmsignal.com/news/RXST/rxsight-inc-reports-first-quarter-2026-results-and-reiterates-full-year-sales-outlook
Ticker: RXST
Company: RxSight
Source: RxSight
Published: 2026-05-06 20:05 EST
Original Source URL: https://investors.rxsight.com
## Summary

ALISO VIEJO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today reported financial results for the quarter ended March 31, 2026. Strategic Highlights and Recent Developments Q1 sales of $30.9 million driven by 27,472 Light Adjustable Lens (LAL) units 20 Light Delivery

## Article Body
ALISO VIEJO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today reported financial results for the quarter ended March 31, 2026. Strategic Highlights and Recent Developments Q1 sales of $30.9 million driven by 27,472 Light Adjustable Lens (LAL) units 20 Light Delivery
## Recent Company News
- 2026-05-19 20:10 EST — [RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum](https://biopharmsignal.com/news/RXST/rxsight-inc-to-present-at-the-stifel-2026-virtual-ophthalmology-forum) — Source: RxSight
- 2026-05-06 20:05 EST — [RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook](https://biopharmsignal.com/news/RXST/rxsight-inc-reports-first-quarter-2026-results-and-reiterates-full-year-sales-outlook) — Source: RxSight
- 2026-04-29 20:10 EST — [RxSight, Inc. to Present at the Bank of America Healthcare Conference](https://biopharmsignal.com/news/RXST/rxsight-inc-to-present-at-the-bank-of-america-healthcare-conference) — Source: RxSight
- 2026-04-22 20:10 EST — [RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6](https://biopharmsignal.com/news/RXST/rxsight-inc-to-report-first-quarter-2026-financial-results-on-may-6) — Source: RxSight
- 2026-04-08 20:05 EST — [RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026](https://biopharmsignal.com/news/RXST/rxsight-highlights-300-000-light-adjustable-lens-implant-milestone-and-strong-scientific-presence-at-ascrs-2026) — Source: RxSight
## Related News
- 2026-07-22 20:05 EST — AZTA — [Azenta Announces Fiscal 2026 Third Quarter Conference Call and Webcast](https://biopharmsignal.com/news/AZTA/azenta-announces-fiscal-2026-third-quarter-conference-call-and-webcast-48419fff)
- 2026-07-22 20:05 EST — VKTX — [Viking Therapeutics to Report Financial Results for Second Quarter 2026 on July 29, 2026](https://biopharmsignal.com/news/VKTX/viking-therapeutics-to-report-financial-results-for-second-quarter-2026-on-july--bbf2553f)
- 2026-07-22 20:01 EST — AXON — [Axon to Release Second Quarter 2026 Earnings on August 5, 2026](https://biopharmsignal.com/news/AXON/axon-to-release-second-quarter-2026-earnings-on-august-5-2026-66120902)
- 2026-07-22 12:39 EST — ARTL — [New Analysis of Over 50 Studies Showed that All the Non-Prescription CBD Products Researched Fell Short of Therapeutic Efficacy — Reinforcing the Case for Artelo's Optimized ART12.11 CBD Composition](https://biopharmsignal.com/news/ARTL/new-analysis-of-over-50-studies-showed-that-all-the-non-prescription-cbd-product-a3445432)
- 2026-07-22 12:30 EST — NRSN — [NeuroSense Advances PrimeC Toward New Drug Submission to Health Canada for ALS](https://biopharmsignal.com/news/NRSN/neurosense-advances-primec-toward-new-drug-submission-to-health-canada-for-als-721c198c)